Art Gilliland

Delinia, Inc. operates as a biotechnology company that develops novel therapeutics for the treatment of autoimmune diseases. Its main program is a molecule that potentiates and expands Regulatory T Cells, powerful immune cells that are critical to maintaining self-tolerance and immune system homeostasis. Tregs are critically important immune regulatory cells in the path physiology of cancer and autoimmune disease. Delinia was founded by Michael Rosenblum and Jeffrey Greve in 2015 and is headquartered in Summit, NJ.

Delinea Corp. provides information technology, outsourcing and consulting services for the energy and utility industries. Its services include outsourcing and service hosting, business development, consulting, training and support. The company also provides infrastructure management, asset management and project management. The firm was founded by Kevin Wright in April, 2000 and is located in Delinea, TX.